RxDoctor Payments Data

Eric Shepard, MD

Anesthesiology · Baltimore, MDNPI 1124061643

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,870 of the $15,879 with a category attached, or 68.5%. Pacira Pharmaceuticals Incorporated accounts for 94.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $12,186 and has fallen 99.8% since, to $21 in 2025. Among anesthesiology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,879in general payments, 2019–2025

Across 38 payments — averaging $417.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$15K
  • Heron Therapeutics, Inc.$361
  • Avanos Medical$138
  • Biohaven Pharmaceutical Holding Company Ltd.$119
  • Brixton Biosciences, Inc.$110
  • Omeros Corporation$34
  • plus $59 from 3 others

What the payments were for

  • Speaking & faculty fees$10,87068%
  • Travel & lodging$3,53922%
  • Food & beverage$1,4709%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,879 in reported general payments places this provider in the 95th percentile of 953 anesthesiology providers in Maryland.

See all anesthesiology providers in Maryland

Medicare billing

Part B allowed, 2024
$9,913
Medicare patients
81
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →